Home
About BRIDION
Introducing BRIDION
Key Facts
Proof of Concept
Pharmacodynamics
Pharmacokinetics
Dose and Administration
Mechanism of Action Video
Prescribing Information
Neuromuscular Blockade
Neuromuscular Blockade
The Ideal NMBA
Clinical Experience
Key Facts
Clinical Efficacy
Clinical Uses
Summary
Safety and Tolerability
Safety
Drug Interactions
Precautions for use
Resources
News Releases
References
Abbreviations and Definitions
Anesthesiologist FAQ’s
Bridion Country Sites
Site Map
About BRIDION
Introducing BRIDION
Key Facts
Proof of Concept
Chemistry
Mechanism of Action
Pharmacodynamics
Preclinical Data
Clinical Data
Pharmacokinetics
Distribution
Elimination
Metabolism
Special Populations
Dose and Administration
Routine Reversal: Moderate and Deep NMB
Immediate Reversal
Special Populations
Method of Administration
Mechanism of Action Video
Prescribing Information
Neuromuscular Blockade
Neuromuscular Blockade
Uses of NMBAs
Mechanism of Action of NMBAs
Monitoring of NMB
Residual NMB
Reversal of NMB
The Ideal NMBA
Clinical Experience
Key Facts
Succinylcholine
Neostigmine
Clinical Efficacy
Routine Reversal: Deep NMB
Routine Reversal: Moderate NMB
Immediate Reversal
Use in Pediatrics
Clinical Uses
Summary
Safety and Tolerability
Safety
Drug Interactions
Precautions for use
Resources
News Releases
References
Abbreviations and Definitions
Anesthesiologist FAQ’s
Bridion Country Sites
Site map
|
About this site
|
Privacy statement
|
Terms of use
|
Prescribing Information
|
About us
© 2008 Schering–Plough Corporation
This website is intended for healthcare professionals outside the United States only.